SUNPHARMA Revenue

Sun Pharmaceutical Industries had revenue of 126.53B INR in the quarter ending June 30, 2024, with 5.96% growth. This brings the company's revenue in the last twelve months to 492.09B, up 9.20% year-over-year. In the fiscal year ending March 31, 2024, Sun Pharmaceutical Industries had annual revenue of 484.97B with 10.51% growth.

Revenue (ttm)

492.09B

Revenue Growth

+9.20%

P/S Ratio

8.89

Revenue / Employee

11.44M

Employees

43,000

Market Cap

4,377.71B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	484.97B	46.11B	10.51%
Mar 31, 2023	438.86B	52.31B	13.53%
Mar 31, 2022	386.54B	51.56B	15.39%
Mar 31, 2021	334.98B	6.61B	2.01%
Mar 31, 2020	328.38B	37.72B	12.98%
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro
Mar 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Reliance Industries Limited	9,252.89B
Tata Consultancy Services Limited	2,441.25B
HDFC Bank Limited	2,663.37B
Bharti Airtel Limited	1,510.49B
ICICI Bank Limited	1,686.78B
Infosys Limited	1,555.41B
State Bank of India	3,319.63B
Hindustan Unilever Limited	621.07B

Revenue Rankings

Sun Pharmaceutical Industries News

1 day ago - Sun Pharma and Moebius Medical get USFDA nod for MM-II for treatment of osteoarthritis knee pain - Business Upturn
3 days ago - Stock Market News: Sona BLW, RIL, PNB Housing Finance, Suzlon among top stocks to watch today (Sept 5, 2024) - Business Upturn
15 days ago - Sun Pharmaceutical introduces STARIZO in India for acute bacterial skin and skin structure infections - Business Upturn
17 days ago - Punjab eyes investments as CM Mann meets industry leaders in Mumbai - The Times of India

More News